Login   |  Users Online: 463 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
CLINICAL RESEARCH
Year : 2011  |  Volume : 32  |  Issue : 2  |  Page : 241-249

A clinical study on the role of Agnimanthadi compound in the management of Sthaulya (obesity)


1 Reader, Department of Panchakarma, SDM College of Ayurveda, Hassan, India
2 Assistant Professor, Department of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India
3 Professor and Head, Department of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India

Correspondence Address:
Mandip Kaur
Assistant Professor, Department of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.92553

Rights and Permissions

Sthaulya (obesity) has become so common in the World's population that it is beginning to replace undernutrition and infectious diseases as the most significant contributor to ill health. It exacerbates a large number of health-related problems, both independently and in association with other diseases. Therefore, this study was carried out at PG Hospital, IPGT and RA, Jamnagar to evaluate effect of Agnimanthadi compound in the patients of Sthaulya. For this purpose 83 patients of Sthaulya were selected out of which 15 patients were dropped out. Remaining 68 patients were treated in two groups. Among these, 38 patients of Sthaulya were treated with Agnimanthadi compound administered orally in the dose of four capsules of 500 mg three times a day with lukewarm water before meal. Remaining 30 patients of Sthaulya were kept as placebo control and were administered orally two placebo capsules of 500 mg filled with starch, three times a day with lukewarm water before meal. The duration of the treatment in both the groups was 7 weeks with follow-up for 2 months. Analysis of overall effects of both the groups showed that Agnimanthadi compound provided markedly better reduction in weight, BMI and other signs and symptoms in the patients of obesity in comparison to the control group.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1704    
    Printed73    
    Emailed1    
    PDF Downloaded426    
    Comments [Add]    

Recommend this journal